Conservative Treatment of A Follicular Ameloblastoma Of The Anterior Mandible: A Case Report by Akerzoul, Narjiss et al.
 Akerzoul N et al. American Journal of Current Surgery 2018, 2:1-7  
  
Ivy Union Publishing | http: //www.ivyunion.org October 25, 2018 | Volume 2 | Issue 1  
Page 1 of 7 
 
 
Conservative Treatment of A Follicular 
Ameloblastoma Of The Anterior Mandible: 
A Case Report 
 
 
Narjiss Akerzoul1*, Saliha Chbicheb2 
 
1Oral surgery Fellow, Department Of Oral Surgery, C.C.D.T, University Mohamed V, Rabat, 
Morocco 
2 Professor, Department Of Oral Surgery, C.C.D.T, University Mohamed V, Rabat, Morocco 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: Anterior Ameloblastoma; Conservative Treatment; Benign Tumor; Mandibular 
Ameloblastoma; Follicular Ameloblastoma 
Received: August 11, 2018; Accepted: September 30, 2018; Published: October *, 2018 
Competing Interests: The authors have declared that no competing interests exist. 
Copyright: 2018 Akerzoul N et al. This is an open-access article distributed under the terms of the 
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction 
in any medium, provided the original author and source are credited. 
*Correspondence to: Narjiss Akerzoul, Oral surgery Fellow, Department Of Oral Surgery, University 
Mohamed V, Rabat, Morocco 
  
 
 
 
Abstract  
Introduction: Ameloblastoma  is a tumor of odontogenic epithelium arising from  remnants of dental 
lamina. It is a benign tumor but locally invasive affecting mandible more than maxilla.  
Presentation of the case: A 36-year-old male patient reported with a swelling on the anterior mandibular 
area and extended to the right side of mandible. Orthopantomogram revealed a unilocular radiolucency 
extending from mesial side of tooth 34 to mesial side of 45. CT Scan showed the extension of the lesion in 
the mesio-distal axis. It also revealed the buccal cortical expansion and the preservation of the internal bone 
cortical. Enucleation conservative treatment was then performed under local anesthesia with extraction of 
the 43. The pathology report concluded a Follicular Unicystic Ameloblastoma. The patient was then 
followed up over a period of one year and showed a notable reduction of the size of the lesion with no signs 
of recurrence. 
Conclusions: Conservative treatment is highly recommended in unicystic follicular patterns of 
ameloblastoma rather than radical treatment. 
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Introduction 
Ameloblastoma was firstly described by Cusack in 1827. It is the most common benign odontogenic tumor 
and represents 13–54% of all benign and malignant tumours of the jaw. There is no distinct gender 
predilection and most cases are diagnosed in the third to fifth decades of life. While rare in children younger 
than age 10 years, it is relatively uncommon in the 10 to 19 year old group [1]. 
 Ameloblastom accounts for about 1% of all oral tumors and about 9-11% of odontogenic tumors. 2 
It is a benign tumor but locally aggressive. There is a slight male preponderance and majority of 
ameloblastomas occur in mandibular ramus region. Although ameloblastomas are primarily intraosseus 
tumors, they have been occasionally reported in soft tissues. They are classified into unicystic, multicystic 
(solid), peripheral and desmoplastic types. Ameloblastoma in the anterior mandible area are rare, and  can 
progress to large size and cause facial asymmetry, displacement of teeth, malocclusion, and pathologic 
fractures. The aim of this paper is to report a rare case of an anterior mandibular follicular ameloblastoma and 
to describe its surgical management. 
Case Report 
A 36-year-old male patient reported with a complaint of swelling on the right side of jaw since 1 year. Initially, 
the swelling was small in size which gradually increased in size. It was a little bit painful but without any pus 
discharge. Patient had no relevant family history and had no habit of smoking. 
On extra-oral examination, the swelling was noted on the anterior mandibular area and extended to the right 
side of mandible (to the mandibular right premolars).  
 On intraoral examination, buccal cortical expansion was visible from tooth 34 to 45 region while the 
lingual cortical preserved (Figure 1). The tooth 44 was absent. The color of the overlying mucosa was normal. 
The lesion was firm in consistency and tender on palpation. Based on all theses findings, many provisional 
diagnosis  were made such as odontogenic adenomatoid tumor, a keratocyst or an ameloblastoma. 
 
 
 
Fig 1 (A) Fig 1 (B) 
FIg 1 (A+B) Intra-oral examination showing the buccal swelling extended from 33 to 45 
 
The patient was subjected to routine radiographic examination. Orthopantomogram revealed a unilocular 
radiolucency measuring about 4.0 × 3.0 cm in size extending from mesial side of tooth 34 to mesial side of 45 
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(Figure 2 A). CT Scan was then performed and showed the extension of the lesion in the mesio-distal axis 
from the mesial side of 34 to mesial side of 45. It also revealed the buccal cortical expansion and the 
preservation of the internal bone cortical (Lingual) (Figure 2 B). 
 
  
Figure 2 (A ) Orthopantomogram showing the extension of the unilocular radiolucent lesion from 34 to 45 
 
 
  
Figure 2 (B) CT Scan showing the extension of the lesion in the Mesio-Distal axis and also revealing the 
preservation of the lingual cortical 
 A buccal flap was raised in order to expose the lesion (Figure 3). Then enucleation conservative 
treatment was then performed under local anesthesia with extraction of the 43 (Figure 4). Hermetic 
post-operative sutures were performed after the surgery (Figure 5). The lesion specimen was then sent for 
histopathological analysis. The pathology report showed follicular cells and concluded a Follicular Unicystic 
Ameloblastoma (Figure 6). The patient was then followed up over a period of one year with no pain or 
discomfort noted and no signs of recurrence (Figure 7). 
                          
 
Figure 3 Intra-Oral View after raising the buccal flap 
with the lesion exposure and its emergence in the 
buccal cortical 
 
Figure 4 Intra-Oral View showing the lesion’s cavity 
after complete enucleation and extraction of the 43 
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Figure 5 Post-operative sutures 
 
Figure 6 Histological image showing the follicular variant 
of ameloblastoma 
 
 
 
 
Figure 7  Follow-Up after one Month 
 
 
 
Figure 8 (A) Figure 8 (B) 
Figure 8 (A+B) One year follow-up: Clinical and radiological Complete healing with no sign of recurrence 
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Discussion 
Ameloblastoma is a benign tumor of odontogenic epithelium principally of enamel organ-type tissue. The 
term ameloblastoma was coined by Ivey and Churchill. Ameloblastoma is the most common benign 
odontogenic tumor and represents 13–54% of all benign and malignant tumours of the jaw. The World Health 
Organization (WHO) defined ameloblastoma as a locally-invasive polymorphic neoplasia that often has a 
follicular or plexiform pattern in a fibrous stroma. Its behaviour has been described as being benign, but 
locally aggressive [1]  Ameloblastomas account for 1% of benign tumors and cysts of the jaw.  Incidence is 
estimated to be 0.5 cases per million person-years worldwide  [2].  The study by Eversole et al, showed that 
ameloblastomas were classified according to the histological findings into follicular, plexiform, 
acanthomatous, granular cell, basal cell, squamous metaplastic, and other rare types [3, 4, 5].  
Ameloblastomas are also classified into unicystic, multicystic, peripheral and desmoplastic types. Robinson 
on reviewing 293 cases reported site incidence of 83.7% in the mandible and 16.3% in the maxilla. 6 
Multicystic/solid is the most common form of ameloblastoma. They can present with huge swellings over the 
jaws which can result in disturbances in facial aesthetics and function, such as difficulty with mouth opening, 
swallowing, chewing, breathing, neurologic deficits, and pathologic fractures. Up to 80 % of ameloblastoma 
cases occur in the mandible, with a predilection for the posterior mandibular region [6,7]. 
 Radiographically solid/multicystic ameloblastoma show an expansile, radiolucent, multiloculated 
cystic lesion, with a characteristic “soap bubble-like” appearance. We can also find a unilocular radiolucent 
lesion, which was the case of our patient who presented an extensive unilocular radiolucent lesion in the 
anterior area of the mandible. Other findings include cystic areas of low attenuation with scattered regions 
representing soft tissue components. There can be thinning and expansion of the cortical plate with erosion 
with the displacement and resorption of adjacent teeth [8].  In our case, we observed only external bony 
infiltration, while the internal cortical was preserved. The bony infiltration  could be correlated with various 
factors secreted by the ameloblast cells. Abdel sayed et al., [9,10] found an increased expression of the 
parathyroid hormone-related protein (PTHrP) in ameloblastoma and suggested that it has a role in local bone 
resorption and also provided an explanation for infiltrative growth and destructive behavior of ameloblastoma. 
Also, other authors found that the RANKL, tumor necrosis factor-•  secreted by ameloblast cells could induce 
the osteoclastogenesis, which in turn provide space for it to expand [11, 12, 13]. 
 There are several histopathological subtypes-follicular, plexiform, acanthomatous, desmoplastic, 
granular cell, and basal cell pattern, that may exist singly or as a combination of two or more types [12].  
Follicular and plexiform are the commonly encountered variants accounting for 32.5% an021d 28.2% 
respectively; followed by the acanthomatous subtype 12.1% while desmoplastic is extremely uncommon with 
incidence rates ranging from 4-13%. Follicular ameloblastoma consists of discrete follicles with similarity to 
the stellate reticulum of enamel organ and with the varying quantity of tissue stroma. Because the follicular 
subtype is the most common variant, some pathologists believe that the acanthomatous, granular cell, basal 
cell, and desmoplastic variants are subsets of the follicular ameloblastoma [14]. 
 Surgery is the standard treatment for ameloblastomas. Historically, the extent of resection has been 
controversial, comprising of two surgical options: « ‘‘conservative’’vs.‘‘radical ». The former involves 
enucleation/curettage of the bony cavity, while the latter involves a radical operation with appropriate margins. 
Advantages of enucleation include the fact that it is an outpatient procedure able to be performed by many 
different service providers (Oral Surgeons and ENT), since it requires no reconstruction. Historical data on 
simple enucleation demonstrates recurrence rates 60–90 %. However, this treatment modality is currently 
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believed to play no role in the management of multicystic  ameloblastomas, but has excellent prognosis for  
the unicystic follicular ameloblastoma as is in our clinical case.  The ‘‘radical’’ surgical option  is the 
current standard of care for multicystic ameloblastoma and includes en bloc resection with 1–2 cm bone 
margins and immediate bone reconstruction to help with speech and  swallowing. The bony margin is 
defined as the distance away from the radiographic margin predicted to be disease free and oncologically safe 
to perform osteotomies [15, 16].  Data from 82 ameloblastoma  specimens showed microscopic tumor 
extension 2–8 mm (mean of 4.5 mm) beyond the radiographic boundaries of the tumor. Hence recommended 
bone margins are 1–1.5 cm for unicystic and 1.5–2 cm for solid/multicystic histological types, and provides 
increased cure rates [17,18]. 
Conclusion 
Ameloblastoma is a benign, but locally invasive odontogenic tumor with a high rate of recurrence. Treatment 
decisions for ameloblastoma are based on the individual patient situation and the judgment of the Oral surgeon. 
Resection with some safe margin is the best primary method for treating solid/multicystic ameloblastomas to 
avoid recurrence, but conservative treatment (enucleation) is highly recommended in unicystic follicular 
patterns rather than radical treatment. 
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